Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Steven Ahrendt

Concepts (259)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Neoplasms
24
2026
103
3.040
Why?
Hyperthermia, Induced
22
2026
119
2.300
Why?
Cytoreduction Surgical Procedures
16
2026
69
2.080
Why?
Pancreatic Neoplasms
16
2024
944
1.410
Why?
Appendiceal Neoplasms
13
2019
28
1.390
Why?
Pancreatectomy
9
2024
289
0.980
Why?
Chemotherapy, Cancer, Regional Perfusion
16
2024
30
0.920
Why?
Antineoplastic Combined Chemotherapy Protocols
19
2026
1998
0.850
Why?
Carcinoma, Pancreatic Ductal
5
2024
297
0.710
Why?
Neoadjuvant Therapy
8
2026
475
0.680
Why?
Adenocarcinoma, Mucinous
7
2020
76
0.630
Why?
Survival Rate
25
2026
2092
0.590
Why?
Colorectal Neoplasms
7
2026
874
0.540
Why?
Prognosis
28
2026
4351
0.510
Why?
Combined Modality Therapy
19
2026
1271
0.500
Why?
Hyperglycemia
1
2020
384
0.470
Why?
Adenocarcinoma
6
2024
927
0.420
Why?
Carcinoma, Signet Ring Cell
4
2016
17
0.410
Why?
Neoplasm Recurrence, Local
7
2019
1160
0.410
Why?
Follow-Up Studies
22
2026
5439
0.370
Why?
Stomach Neoplasms
3
2024
128
0.370
Why?
Lung Neoplasms
7
2019
2675
0.350
Why?
Mesothelioma
3
2016
50
0.320
Why?
Chemotherapy, Adjuvant
9
2026
429
0.290
Why?
Biomarkers, Tumor
4
2015
1339
0.290
Why?
Neoplasm Staging
13
2022
1488
0.280
Why?
Neoplasm Grading
9
2015
313
0.280
Why?
Middle Aged
40
2026
36619
0.280
Why?
Retrospective Studies
21
2026
17438
0.270
Why?
Genes, p53
3
2003
56
0.270
Why?
Cholangitis, Sclerosing
2
1999
56
0.270
Why?
Lymphatic Metastasis
9
2024
335
0.260
Why?
Carcinoma, Non-Small-Cell Lung
3
2003
1195
0.260
Why?
Fluorouracil
3
2024
231
0.260
Why?
Postoperative Complications
7
2025
3034
0.250
Why?
Prospective Studies
19
2025
8123
0.250
Why?
Bile Duct Neoplasms
2
2018
132
0.250
Why?
Aged
28
2026
26432
0.250
Why?
Endophytes
1
2026
5
0.240
Why?
Poaceae
1
2026
37
0.230
Why?
Survival Analysis
8
2016
1378
0.230
Why?
Laparoscopy
2
2021
487
0.230
Why?
Smad4 Protein
1
2005
33
0.220
Why?
Fungi
1
2026
120
0.220
Why?
Neoplasms, Second Primary
1
2026
103
0.220
Why?
Genes, ras
3
2002
70
0.210
Why?
Male
43
2026
73396
0.210
Why?
Mutation
6
2014
4093
0.210
Why?
Female
43
2026
79499
0.200
Why?
Urologic Surgical Procedures
1
2025
126
0.200
Why?
Antineoplastic Agents
4
2021
2219
0.200
Why?
Thymidylate Synthase
1
2003
13
0.200
Why?
Armillaria
1
2023
3
0.200
Why?
Coelomomyces
1
2023
1
0.200
Why?
Anopheles
1
2023
18
0.190
Why?
Lentinula
1
2023
1
0.190
Why?
Humans
52
2026
146342
0.190
Why?
Antimetabolites, Antineoplastic
1
2003
108
0.190
Why?
Parasites
1
2023
44
0.190
Why?
Vascular Endothelial Growth Factor A
1
2005
545
0.190
Why?
Carcinoma
3
2015
225
0.180
Why?
Adaptation, Physiological
1
2026
568
0.170
Why?
Pancreaticoduodenectomy
2
2021
149
0.170
Why?
CA-19-9 Antigen
3
2022
36
0.170
Why?
Proportional Hazards Models
6
2022
1331
0.170
Why?
Pancreatic Cyst
1
2002
50
0.170
Why?
Nomograms
1
2022
59
0.170
Why?
Body Composition
1
2024
689
0.160
Why?
Cyclins
1
2000
77
0.160
Why?
Cystadenoma, Serous
1
2020
18
0.160
Why?
Neuroendocrine Tumors
1
2002
122
0.150
Why?
Databases, Factual
2
2024
1493
0.150
Why?
Genome, Fungal
2
2026
48
0.150
Why?
Pseudomyxoma Peritonei
1
2019
5
0.140
Why?
Cystadenocarcinoma, Serous
1
2020
90
0.140
Why?
Bile Ducts, Intrahepatic
1
1999
62
0.140
Why?
Adult
21
2026
41087
0.140
Why?
Pleural Neoplasms
1
2019
31
0.140
Why?
Kaplan-Meier Estimate
6
2016
970
0.140
Why?
Adenoma
1
2020
210
0.130
Why?
Aged, 80 and over
10
2021
8391
0.130
Why?
Cholangiocarcinoma
1
1999
110
0.130
Why?
Neoplasm Metastasis
2
2018
693
0.130
Why?
Patient Compliance
1
2021
589
0.130
Why?
Treatment Outcome
10
2025
11821
0.130
Why?
Genomics
2
2026
853
0.120
Why?
Wearable Electronic Devices
1
2018
75
0.120
Why?
Sequence Analysis, DNA
2
2016
771
0.120
Why?
Carcinoid Tumor
1
2016
21
0.120
Why?
Gastrointestinal Neoplasms
1
2016
74
0.120
Why?
Depression
2
2016
1575
0.110
Why?
Telomerase
1
1997
252
0.110
Why?
Bile
1
1994
26
0.110
Why?
Glucose
1
2020
1053
0.110
Why?
Pancreatic Fistula
1
2014
35
0.110
Why?
GTP-Binding Protein alpha Subunits, Gs
1
2014
9
0.100
Why?
Learning Curve
1
2014
71
0.100
Why?
Age Factors
4
2022
3347
0.100
Why?
Microsporidia
1
2013
2
0.100
Why?
Phylogeny
3
2026
924
0.100
Why?
Inpatients
1
2018
540
0.100
Why?
Chytridiomycota
1
2013
27
0.100
Why?
Immunohistochemistry
4
2016
1712
0.100
Why?
DNA, Fungal
1
2013
76
0.100
Why?
Molecular Diagnostic Techniques
1
2014
104
0.100
Why?
Walking
1
2018
546
0.090
Why?
CA-125 Antigen
1
2012
13
0.090
Why?
Cholesterol
1
1994
411
0.090
Why?
Appendectomy
1
2013
93
0.090
Why?
Carcinoembryonic Antigen
2
2024
40
0.090
Why?
Patient Readmission
1
2018
778
0.090
Why?
Fatigue
1
2014
363
0.090
Why?
Gastrectomy
1
2013
164
0.090
Why?
Oligonucleotide Array Sequence Analysis
2
2003
752
0.080
Why?
Leucovorin
2
2024
98
0.080
Why?
Predictive Value of Tests
3
2014
2113
0.080
Why?
Sarcoma
1
2013
209
0.080
Why?
Disease-Free Survival
3
2013
778
0.080
Why?
Kidney Diseases
1
2014
428
0.080
Why?
DNA Mutational Analysis
3
2016
410
0.070
Why?
Morbidity
3
2016
319
0.070
Why?
Registries
1
2018
2400
0.070
Why?
Quality of Life
2
2019
3200
0.070
Why?
Mitomycin
3
2013
31
0.070
Why?
Cisplatin
3
2016
347
0.070
Why?
Sex Factors
2
2022
2107
0.060
Why?
Lung Diseases
1
2014
787
0.060
Why?
Lymph Nodes
2
2002
511
0.060
Why?
Alternaria
1
2026
9
0.060
Why?
Antarctic Regions
1
2026
24
0.060
Why?
Antineoplastic Protocols
1
2025
6
0.060
Why?
Neoplasm Invasiveness
2
2020
504
0.060
Why?
Thymidine Phosphorylase
1
2005
13
0.060
Why?
Peritoneum
1
2025
44
0.060
Why?
Injections, Intraperitoneal
2
2016
115
0.060
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2005
49
0.060
Why?
Angiogenesis Inducing Agents
1
2005
24
0.060
Why?
Infusions, Parenteral
2
2016
47
0.050
Why?
Microcirculation
1
2005
142
0.050
Why?
Radiotherapy, Adjuvant
1
2005
222
0.050
Why?
Polymerase Chain Reaction
3
2016
1031
0.050
Why?
Biomarkers
2
2014
4340
0.050
Why?
Cold Temperature
1
2026
208
0.050
Why?
Multivariate Analysis
2
2014
1543
0.050
Why?
Anthropometry
1
2024
204
0.050
Why?
Angiogenesis Inhibitors
1
2005
239
0.050
Why?
Crustacea
1
2023
5
0.050
Why?
Adolescent
6
2022
22557
0.050
Why?
Risk Assessment
3
2016
3712
0.050
Why?
Forecasting
1
2005
388
0.050
Why?
Gene Transfer, Horizontal
1
2023
34
0.050
Why?
Dideoxynucleosides
1
2003
27
0.050
Why?
Agaricus
1
2023
3
0.050
Why?
Pennsylvania
2
2014
136
0.050
Why?
Thailand
1
2023
20
0.050
Why?
Biomass
1
2023
96
0.050
Why?
Young Adult
5
2022
14330
0.050
Why?
Time Factors
3
2025
7109
0.050
Why?
Inflammation
1
2014
2919
0.050
Why?
Larva
1
2023
242
0.050
Why?
Genetic Markers
1
2003
340
0.050
Why?
Risk Factors
3
2024
10921
0.040
Why?
Plants
1
2023
168
0.040
Why?
Liver Transplantation
2
1999
751
0.040
Why?
Intraoperative Care
1
2002
68
0.040
Why?
Biopsy, Needle
1
2002
183
0.040
Why?
Regression Analysis
1
2003
999
0.040
Why?
Chemoradiotherapy
1
2022
238
0.040
Why?
Obesity
1
2014
3131
0.040
Why?
Tumor Burden
1
2022
326
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2000
104
0.040
Why?
Adipose Tissue
1
2024
642
0.040
Why?
Actuarial Analysis
1
1999
15
0.040
Why?
Perioperative Care
1
2002
235
0.040
Why?
Bile Ducts, Extrahepatic
1
1999
19
0.040
Why?
Ecosystem
1
2023
483
0.040
Why?
Neoplasms
1
2014
2954
0.040
Why?
France
1
2018
40
0.030
Why?
Promoter Regions, Genetic
1
2003
1242
0.030
Why?
DNA Methylation
1
2003
725
0.030
Why?
Liver Neoplasms
1
2024
776
0.030
Why?
Dilatation
1
1998
73
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2003
1432
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2013
974
0.030
Why?
Hepatectomy
1
1999
256
0.030
Why?
Cause of Death
1
1999
456
0.030
Why?
Organoplatinum Compounds
1
2016
65
0.030
Why?
Microdissection
1
2016
13
0.030
Why?
Linear Models
1
1999
857
0.030
Why?
Sensitivity and Specificity
1
2002
1998
0.030
Why?
Comorbidity
1
2022
1665
0.030
Why?
Postoperative Period
1
2018
355
0.030
Why?
Goblet Cells
1
2016
22
0.030
Why?
Transcriptome
1
2023
1068
0.030
Why?
Microsatellite Instability
1
2016
57
0.030
Why?
Tumor Suppressor Protein p53
1
2000
530
0.030
Why?
DNA Mismatch Repair
1
2016
54
0.030
Why?
Diagnostic Imaging
1
1999
340
0.030
Why?
Peritoneal Cavity
1
2016
30
0.030
Why?
Camptothecin
1
2016
139
0.030
Why?
Immunoenzyme Techniques
1
2015
197
0.030
Why?
Cholelithiasis
1
1994
37
0.030
Why?
Inflammatory Bowel Diseases
1
1999
352
0.030
Why?
Micelles
1
1994
38
0.030
Why?
Chromogranins
1
2014
13
0.030
Why?
Crystallization
1
1994
131
0.030
Why?
Necrosis
1
2015
243
0.030
Why?
Loss of Heterozygosity
1
2014
51
0.030
Why?
Preoperative Period
1
2014
157
0.020
Why?
Molecular Targeted Therapy
1
2016
447
0.020
Why?
Stents
1
1998
554
0.020
Why?
Reoperation
1
2016
645
0.020
Why?
Mortality
1
2016
375
0.020
Why?
Odds Ratio
1
2016
1077
0.020
Why?
Sarcoma, Synovial
1
2013
20
0.020
Why?
Phospholipids
1
1994
215
0.020
Why?
Cell Wall
1
2013
61
0.020
Why?
ras Proteins
1
2014
148
0.020
Why?
Leiomyosarcoma
1
2013
30
0.020
Why?
Chi-Square Distribution
1
2014
517
0.020
Why?
Proto-Oncogene Proteins p21(ras)
1
2014
250
0.020
Why?
Liposarcoma
1
2013
31
0.020
Why?
Gastrointestinal Stromal Tumors
1
2013
41
0.020
Why?
Omentum
1
2012
9
0.020
Why?
Precision Medicine
1
2016
462
0.020
Why?
Incidence
1
1999
2936
0.020
Why?
DNA Damage
1
2015
439
0.020
Why?
Splenectomy
1
2012
61
0.020
Why?
C-Reactive Protein
1
2014
429
0.020
Why?
Length of Stay
1
1998
1358
0.020
Why?
Tomography, X-Ray Computed
1
2002
2786
0.020
Why?
Antibiotics, Antineoplastic
1
2012
141
0.020
Why?
United States
2
2021
16136
0.020
Why?
Proto-Oncogene Proteins
1
2014
616
0.020
Why?
Biopsy
1
2014
1075
0.020
Why?
Doxorubicin
1
2013
416
0.020
Why?
Analysis of Variance
1
2013
1298
0.020
Why?
Interleukin-6
1
2014
784
0.020
Why?
Evolution, Molecular
1
2013
502
0.020
Why?
Tumor Necrosis Factor-alpha
1
2014
1224
0.020
Why?
Molecular Sequence Data
1
2013
2838
0.020
Why?
Cell Differentiation
1
2016
1982
0.020
Why?
Child
2
1999
22693
0.020
Why?
Case-Control Studies
1
1994
3647
0.020
Why?
Body Mass Index
1
2014
2458
0.010
Why?
O(6)-Methylguanine-DNA Methyltransferase
1
2003
6
0.010
Why?
Sulfites
1
2003
8
0.010
Why?
Glutathione S-Transferase pi
1
2003
10
0.010
Why?
Adenomatous Polyposis Coli Protein
1
2003
20
0.010
Why?
Glutathione Transferase
1
2003
92
0.010
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2003
74
0.010
Why?
Isoenzymes
1
2003
294
0.010
Why?
Surveys and Questionnaires
1
2014
6073
0.010
Why?
Polymorphism, Restriction Fragment Length
1
2001
57
0.010
Why?
Animals
1
2023
38106
0.010
Why?
Codon
1
2001
92
0.010
Why?
Transcription, Genetic
1
2003
1432
0.010
Why?
DNA
1
2003
1421
0.010
Why?
Reproducibility of Results
1
2001
3416
0.010
Why?
Ahrendt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)